EVISA - Who we are
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
Particles floating in (not necessarily on) a liquid medium, or the mix of particles and liquid itself.
The term "suspension" was found in the following pages:
FDA identifies no harmful effects to date with brain retention of gadolinium-based contrast agents for MRIs | EVISA's News
EMA Issues Final Opinion Limiting Gadolinium Contrast Agents in Body Scans | EVISA's News
European Medicines Agency recomments to pull linear Gadolinium-based MRI contrast agents from market | EVISA's News
Material database: National Institute of Standards and Technology (NIST) - SRM 616/617 - Trace Elements in Glass
FDA panel calls for warning labels on gadolinium-based contrast agents for MRI | EVISA's News
European Medicines Agency recommends to pull linear Gadolinium-based MRI contrast agents from market | EVISA's News
Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls | EVISA's News
South Korea: 13 gadolinium contrast agents banned until year-end | EVISA's News
Roxarsone and it metabolites in organic fertilizer lead to human exposure to arsenic | EVISA's News
See the complete list of deadlines!
6th FFF-MS Workshop
Federal Institute of Hydrology (BfG) in Koblenz, Germany
18th European Winter Conference on Plasma Spectrochemistry 2019
PittCon 2019: 70th Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy
... more Events
What's new on EVISA's web site ?
The European Commission has put on hold plans to increase maximum authorised mercury level in fish
EU agrees on maximum cadmium level in fertilisers
Imaging and Identification of Sulfur Species within Corals by X-ray Spectroscopy
Quantification of polybrominated diphenyl ethers by means of GC-ICP-MS
... more News
You have forgotten your password ?
© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )